Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oncotec Pharma is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the aseptic filling and production of cytostatic and cytotoxic liquid and lyophilized drugs. Located in the BioPharmaPark Dessau, Germany, the company provides a comprehensive range of services from formulation development and clinical trial supply to large-scale commercial manufacturing. Their core expertise lies in handling highly potent active pharmaceutical ingredients (HPAPIs) using advanced isolator technology for both vials and pre-filled syringes. As a subsidiary of Medac, Oncotec serves a global client base, ensuring high-quality standards for complex oncology and autoimmune therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oncotec Pharma.